Search results
FDA Approves Moderna’s mRESVIA Vaccine | JD Supra
JD Supra· 1 day agoOn May 31, 2024, Moderna announced that the FDA has approved its respiratory syncytial virus vaccine (“RSV”), mRESVIA (mRNA-1345). The vaccine...
Is Moderna Inc (MRNA) Set to Underperform? Analyzing the Factors
Guru Focus· 22 hours agoLong-established in the Biotechnology industry, Moderna Inc (MRNA, Financial) has enjoyed a stellar reputation. Notably, its diminished rankings in financial strength, growth ...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 1 day agoThe company also unveiled promising results in people age 18 to 59 years old with underlying...
What the Options Market Tells Us About Moderna - Moderna (NASDAQ:MRNA)
Benzinga· 22 hours agoLoading... Loading... Deep-pocketed investors have adopted a bullish approach towards Moderna MRNA , and it's something market players shouldn't ignore. Our tracking of public ...
How Moderna’s newly approved RSV vaccine could impact 2024 revenue - Boston Business Journal
The Business Journals· 5 days agoOn Friday, Moderna Inc. (Nasdaq: MRNA) notched its second-ever FDA product approval, this time for...
Promising trial data for Moderna-Merck skin cancer vaccine sends stock rising
Quartz· 5 days agoModerna stock jumped nearly 4% on Tuesday after the the company announced positive data from an...
Moderna, Merck say vaccine improved survival in patients with deadly skin cancer
CNBC· 5 days agoModerna and Merck released more positive three-year data Monday on their experimental vaccine, given...
Promising Trial Results Show New Standards In Cancer Treatment And Diagnostics Are On The Horizon
Benzinga via Yahoo Finance· 4 days agoOn Friday, Pfizer Inc (NYSE: PFE) revealed its drug for an advanced form of lung cancer showed...
Moderna, Merck shares rise as combined melanoma therapy shows improved survival rate By...
Investing.com· 5 days agoModerna (NASDAQ:MRNA) and Merck (MRK) have released new, more encouraging three-year data on their...
Study shows new cancer vaccine to treat melanoma has 96% survival rate
UNILAD· 4 days agoA new vaccine treatment for skin cancer melanoma has shown extremely promising results in a new...